Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amunix Announces the Appointment of Healthcare Investment Banking Veteran Zeeshan Merchant as ...
Amunix Pharmaceuticals, Inc.January 26, 2021 GMT
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers, today announced the appointment of Zeeshan Merchant as Chief Financial Officer and Trisha Millican to the Board of Directors.
Mr. Merchant joins Amunix with over 15 years of experience in biotechnology as an investment banker and investor. He joins from Morgan Stanley, where he served as an Executive Director in the healthcare investment banking group, advising biotechnology companies on financings and strategic matters.